$XBI
two recent themes, highlighted in last week’s biotech hangout, seemed center stage this week:
the negative influence of “funding” shorts (and short shorts) on specialists’ books:
$APGE and $CRNX takeouts previously
$mRNA rather unexpected reverse shock
and the pair